Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Nature Genetics2004Vol. 36(6), pp. 585–595
Citations Over TimeTop 1% of 2004 papers
Brinda Ravikumar, Corinne Vacher, Zdenek Berger, J. Eric Davies, Shouqing Luo, Lourdes Garcia Oroz, Francesco Scaravilli, Douglas F. Easton, Rainer Duden, Cahir J. O’Kane, David C. Rubinsztein
Related Papers
- → Targeting mTOR globally in cancer: Thinking beyond rapamycin(2009)155 cited
- → Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies(2020)121 cited
- → The functions of mTOR in ischemic diseases(2011)58 cited
- → Adaptation to chronic mTOR inhibition in cancer and in aging(2013)13 cited
- → Quantitative phosphoproteomics reveal that mTOR regulates cell growth and proliferation by phosphorylating a functionally diverse set of substrates(2012)